Advertisement

Topics

Latest "Biogen Incorporated" News Stories

21:23 EDT 24th May 2018 | BioPortfolio

Here are the most relevant search results for "Biogen Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Biogen Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biogen Incorporated for you to read. Along with our medical data and news we also list Biogen Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biogen Incorporated Companies for you to search.

Showing "Biogen Incorporated" News Articles 1–25 of 460

Thursday 24th May 2018

ArQule Strengthens Executive Team with Two Key Appointments

Newly Created Positions of Senior Vice President, Corporate Strategy, Communication & Finance and Senior Vice President, Program Management and Product Planning ArQule, Inc. (NASDAQ: ARQL) today announced two strategic additions to its executive team, appointing Dr. Marc Schegerin as senior vice president, corporate strategy, communication and fina...


Independent Stent Imaging Study Shows Excellent Healing Profile with Resolute Onyx DES in Complex Patients with Coronary Artery Disease

Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained a high percentage of patients with complex coronary artery dis...

Monday 21st May 2018

BIO 2018 Convention to Feature Actor, Director and Advocate Rob Reiner as Keynote Speaker

Reiner’s family story of drug addiction reinforces the urgent need for biotechnology innovation in pain management The Biotechnology Innovation Organization (BIO) announced that actor, director and advocate Rob Reiner will deliver a keynote address at the 2018 BIO International Convention, the world’s premier life sciences event being hel...


EMA confirms risks of MS drug Zinbryta

The European Medicines Agency has concluded that the risks linked with use of Biogen and AbbVie's multiple sclerosis drug Zinbryta outweigh its benefits.

EMA review confirms risks of Abbvie and Biogen's Zinbryta outweigh benefits

The EMA has judged that the benefits offered by Zinbryta (daclizumab), Abbvie and Biogen’s humanised IgG1 monoclonal antibody for the treatment of multiple sclerosis (MS), do not outweigh its risks, following a review carried out by the agency’s Pharmacovigilance Risk Assessment Committee (PRAC) at the request of the European Commission. read more

Friday 18th May 2018

Biogen intends to increase stake in Samsung Bioepis

Wednesday 16th May 2018

Herbalife Nutrition Announces the Adjusted Price Range of Its Dutch Auction Tender Offer for Common Shares Following Stock-Split

Herbalife Nutrition Ltd. (NYSE: HLF) (“Herbalife Nutrition” or “the Company”) announced today the adjusted price range of its tender offer for Herbalife Nutrition’s common shares, par value $0.0005 per share (“shares”), wherein the Company is seeking to purchase up to $600 million in shares. Following the adjustment to reflect the Company’s ...

Biotech Report: Biogen und Amgen ziehen an

shareribs.com - Biotech-Aktien zeigten sich im deutschen Handel wenig verändert. An der Wall Street hingegen gibt es bei Amgen und Biogen kräftige Kursgewinne Den vollständigen Artikel lesen ......

Friday 11th May 2018

Biogen Is Set for a Tradable Rally

Click to view a price quote on BIIB.

Wednesday 9th May 2018

You’ll Be Blown Away By These Biotech Jobs!

Hello biotechnologists, Hold onto your hats! These biotech jobs will blow you away 😉 Check out the in vivo pharmacology position at Galapagos or become a genomics marketing development manager at Illumina. Just starting out? Check out the internship in manufacturing documentation at Biogen! Research ... This awesome article You’ll Be Blown Away By These Biotech Jobs! appeared fi...

Tuesday 8th May 2018

Ligand Reports First Quarter 2018 Financial Results

Conference Call Begins at 4:30 p.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement...

Mannatech Reports First Quarter 2018 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2018. First Quarter Results

Monday 7th May 2018

Biogen Celebrates 40 Years as a Pioneer in Neuroscience

Members of the Media are Invited to Join Us for Our 40th Anniversary Event “Biogen in Neuroscience: Past, Present & Future” Biogen (Nasdaq:BIIB): Who/What:On Monday, May 14, 2018, Biogen (Nasdaq: BIIB), one of the world’s first global biotechnology companies, will commemorate its 40th anniversary with a special...

Swiss Biotech Association Honors Selexis Among Its Inaugural Group of Swiss Biotech Success Stories

Company Among Five 2018 Laureates Recognized for Important, Sustainable Contributions to the Biotech Industry in Switzerland Selexis SA today announced that the Swiss Biotech Association (SBA) has named Selexis to an esteemed group of five Swiss Biotech Success Stories, as determined by a jury of industry experts, based upon the company’s cont...

Friday 4th May 2018

Rebuilding Biogen’s brain

Biogen has made progress in rebuilding its early- and mid-stage neuro pipeline but has its work cut out for balancing risk in its Phase III programs.

US FDA issues biosimilar CRL to ‘disappointed’ but determined Sandoz

The US FDA has rejected Sandozâs proposed biosimilar version of Biogen and Rocheâs Rituxan (rituximab).

The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories

Basel, Switzerland, May 04, 2018 / B3C newswire / -- On the occasion of its 20th anniversary, the Swiss Biotech Association launches Swiss Biotech Success Stories in recognition of the industry’s many accomplishments. Swiss Biotech Success Stories will grow over time to encompass all of the industry’s different facets. An independent jury of experts annually selects the laureates. The first r...

Nicox Provides First Quarter 2018 Business and Financial Results

Press Release Nicox Provides First Quarter 2018 Business  and Financial Results ..............................................   May 4, 2018 - release at 7:30 am CET Sophia Antipolis, France   Nicox SA (

Thursday 3rd May 2018

Teleflex Reports First Quarter 2018 Results

First Quarter Revenues of $587.2 million, up 20.4% Versus Prior Year Period; up 14.6% on Constant Currency Basis First Quarter GAAP Diluted EPS of $1.18, up 35.6% Over the Prior Year Period First Quarter Adjusted Diluted EPS of $2.15, up 19.4% Versus Prior Year Period Raised 2018 Guidance Range for GAAP Revenue Growth from...

New Ways to Attack Atopic Dermatitis: Realm Expects POC Next Quarter

Realm Therapeutics is evaluating a substance derived from insights into innate immunity that has potential as an immunomodulator in various...   

Lilly, Pfizer, Sanofi lead in patent litigation, report says

The most litigated cases in 2016 and 2017 were over Biogen's MS drug Tecfidera, Amgen's Sensipar and Bristol-Myers Squibb and Pfizer's anticoagulant Eliquis.

Sandoz US woes continue with biosimilar rejection

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – with sales of the generics unit down by 18%. Only adding to its troubles in the US market, it just announced that the FDA has issued a complete response later in regards to the unit’s application for its biosimilar GP2013. The biosimilar would have entered the market a...

Wednesday 2nd May 2018

Biogen to Receive the Lifetime Achievement Award at Boston CEO, Taking Place May 9-10, 2018

This year's award ceremony will convene industry thought leaders to recognize the accomplishments of a local biotech success story. BOSTON (PRWEB) May 02, 2018 Boston Biotech Conferences is hosting Boston CEO, a peer-to-peer meeting taking place May 9-10, 2018 at the Four Seasons Hotel in Boston, Massachusetts. In one week, thought leaders from several of the world’s leading bio-pharmaceuti...

Samsung BioLogics Under Spotlight Over Accounting Handling Of Biogen JV

Samsung BioLogics shares plunge on suspicions it has violated accounting related to affiliate Samsung Bioepis, but the company says its...   

Bidders Hike Offers For India’s Fortis As Acquisition War Intensifies

Leading Malaysian healthcare operator IHH and two Indian tycoons have sweetened their offers for cash-strapped Fortis Healthcare as the race...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks